News Search Results
May 13, 2026, 16:30 ET Armata Pharmaceuticals Announces First Quarter 2026 Results and Provides Corporate Update
May 13, 2026 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a late clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat
More news about: Armata Pharmaceuticals, Inc.
May 13, 2026, 16:05 ET INOVIO Reports First Quarter 2026 Financial Results and Recent Business Highlights
PLYMOUTH MEETING, Pa., May 13, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious
More news about: INOVIO Pharmaceuticals, Inc.
May 13, 2026, 15:35 ET Frost & Sullivan Explores the Rise of the "Healthspan Economy" and Emerging Growth Opportunities in Nutraceuticals
phase of growth will be led by integrated, science-backed solutions that extend healthspan, not just lifespan. Companies that combine nutrition, biotechnology, and personalised health insights to address mobility, cognition, and metabolic resilience will shape the future of healthy aging and longevity."The
More news about: Frost & Sullivan
May 13, 2026, 15:35 ET Frost & Sullivan Explores the Rise of the "Healthspan Economy" and Emerging Growth Opportunities in Nutraceuticals
phase of growth will be led by integrated, science-backed solutions that extend healthspan, not just lifespan. Companies that combine nutrition, biotechnology, and personalised health insights to address mobility, cognition, and metabolic resilience will shape the future of healthy aging and longevity."The
More news about: Frost & Sullivan
May 13, 2026, 14:30 ET Xtalks Named Media Partner for the Canadian Pharma & Biotech PPM Summit Toronto
Why Summits, the event will convene senior leaders from pharmaceutical and biotechnology organizations, as well as CROs, technology providers and consulting firms, to examine the evolving role of portfolio management in today's life
More news about: Xtalks
May 13, 2026, 14:11 ET Lupin Receives U.S. FDA Approval for Famotidine Injection, USP
products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position
More news about: Lupin Pharmaceuticals, Inc.
May 13, 2026, 12:16 ET Non-Animal Alternative Testing Market Size to Reach $29.4 Billion by 2030, Globally, at 13.5% CAGR: Allied Market Research
The North America non-animal alternative testing market was the largest because of U.S. Having the biggest concentration of pharmaceutical and biotechnology companies, robust R&D ecosystem, and includes key players in the market such as Abbott Laboratories. An ageing population along with increasing
More news about: Allied Market Research
May 13, 2026, 12:00 ET Elabscience® Launches Self-Developed PolyHRP-Streptavidin Conjugate for Low-Abundance Biomarker Detection in ELISA
high-throughput ELISA applications.About Elabscience® Bionovation Inc. Elabscience® Bionovation Inc. is a biotechnology company focused on the design, development, manufacturing, and sale of research reagents and services for cell detection and life sciences applications.
More news about: Elabscience® Bionovation Inc.
May 13, 2026, 11:49 ET Beam Therapeutics Supports AlphaDetect to Accelerate Detection of Alpha-1
[email protected] Beam TherapeuticsBeam Therapeutics (Nasdaq: BEAM) is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled
More news about: Alpha-1 Foundation
May 13, 2026, 09:15 ET Autoimmunity BioSolutions Expands Seed Funding Round and Deepens Family Office Participation
Autoimmunity BioSolutions (ABS), a biotechnology company developing a personalized, genetically-guided immuno-corrective therapy designed to normalize elevated levels of soluble IL7 receptor (sIL7R),
More news about: Autoimmunity BioSolutions
May 13, 2026, 09:15 ET AndzonBio2, the ALBORADA Drug Discovery Institute at the University of Cambridge and Cambridge Enterprise Announce a Collaboration to Develop First-in-Class Therapeutics for Neuroinflammation
of Cambridge bridges the gap between the deep disease understanding of academia and the drug development capabilities within the pharmaceutical/biotechnology industry and clinical centres of excellence. The ADDI is part of a wider Drug Discovery Alliance, funded by the charity Alzheimer's Research UK
More news about: AndzonBio2
May 13, 2026, 09:00 ET Sameh Samir Ali Honored by the Egyptian Embassy in Beijing Following a Decade of Scientific Innovation and International Recognition at Jiangsu University
complex organic waste can be biologically converted into high-value bioenergy resources, opening new interdisciplinary directions in environmental biotechnology.The international scope of Prof. Ali's research has also fostered long-term collaborations with leading scientists and research institutions
More news about: Jiangsu University
May 13, 2026, 08:04 ET ERS Genomics and Aurigene Sign CRISPR/Cas9 License Agreement to Advance Precision Genome Editing in Drug Discovery
can integrate precision genome editing capabilities into its discovery platforms, strengthening its ability to support global pharmaceutical and biotechnology partners across small molecule and biologics programs.Akhil Ravi, Chief Executive Officer, Aurigene Pharmaceutical Services Limited,
More news about: ERS Genomics
May 13, 2026, 08:00 ET Stellaromics® Appoints Veronica Mankinen as SVP Global Commercial Operations and John Leamon as SVP Product Development
company's flagship STARmap™ and RIBOmap™ technologies.John Leamon, Ph.D. – SVP Product DevelopmentDr. Leamon is a veteran of the biotechnology industry with a proven track record of bringing ground-breaking genomic platforms from concept to market. He previously served as Executive Director,
More news about: Stellaromics
May 13, 2026, 08:00 ET BRAINBox Solutions Announces Appointment of Richard H. Noel as Chief Product and Commercial Officer
entering the diagnostics industry, Mr. Noel taught honors physics, chemistry, and cognitive neuroscience. He holds a Master's degree in Business and Biotechnology from the University of Utah and a Bachelor's degree in Psychology from UC San Diego.About BRAINBox SolutionsBRAINBox Solutions
More news about: BRAINBox Solutions, Inc.
May 13, 2026, 08:00 ET Tyra Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights
CARLSBAD, Calif., May 13, 2026 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology,
More news about: Tyra Biosciences
May 13, 2026, 07:30 ET Palatin Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
complete clinical trials and submit applications for regulatory approvals, products developed by competing pharmaceutical, biopharmaceutical and biotechnology companies, commercial acceptance of Palatin's products, and other factors discussed in Palatin's periodic filings with the Securities and Exchange
More news about: Palatin Technologies, Inc.
May 13, 2026, 07:00 ET Paterna Biosciences Announces World-First Achievement: Lab-Grown Human Sperm
SALT LAKE CITY, May 13, 2026 /PRNewswire/ -- Paterna Biosciences, a fertility biotechnology company pioneering male reproductive medicine, has announced a landmark scientific achievement: the company has grown functional human sperm entirely
More news about: Paterna Biosciences
May 13, 2026, 06:30 ET Immunic, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update
Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today announced financial results for the first quarter ended
More news about: Immunic, Inc.
May 13, 2026, 06:07 ET European Inventor Award 2026 finalists revealed
work is helping to address some of the most critical global challenges. This year's finalists have developed inventions spanning sectors including biotechnology, healthcare, renewable energy, semiconductors, digital technologies, food technology, quantum, rail transport and advanced manufacturing.
More news about: European Patent Office (EPO)
May 13, 2026, 03:15 ET AndzonBio2, the ALBORADA Drug Discovery Institute at the University of Cambridge and Cambridge Enterprise Announce a Collaboration to Develop First-in-Class Therapeutics for Neuroinflammation
of Cambridge bridges the gap between the deep disease understanding of academia and the drug development capabilities within the pharmaceutical/biotechnology industry and clinical centres of excellence. The ADDI is part of a wider Drug Discovery Alliance, funded by the charity Alzheimer's Research UK
More news about: AndzonBio2
May 12, 2026, 21:02 ET PharmaResearch Completes Five-Market Western Europe Roadshow for REJURAN
DESIRIAL®, the world's first injectable for functional and aesthetic gynaecology. VIVACY recently entered into strategic partnerships with Burgeon Biotechnology for the NOVUMA® CaHA biostimulator, and with PharmaResearch for the exclusive European distribution of the REJURAN® PN-based skin booster. With
More news about: PharmaResearch Co., Ltd.
May 12, 2026, 18:01 ET Lilly's Foundayo and lower-dose Zepbound helped people maintain weight loss after switching from higher doses of injectable incretin therapy in two late-phase trials
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
May 12, 2026, 16:30 ET Corteva Announces Headquarters for Two Future Companies Following Planned Separation
be headquartered in Johnston, Iowa, home of its flagship Pioneer brand and more than a century of innovation. Anchored in elite germplasm and cutting-edge biotechnology, Vylor will advance its seed and genetics business while exploring opportunities to expand to new crops – and potentially beyond. Vylor will also
More news about: Corteva Agriscience
May 12, 2026, 16:00 ET Curis Provides First Quarter 2026 Business Update
LEXINGTON, Mass., May 12, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor, today reported its business
More news about: Curis, Inc.